TrialAntimicrobial agents and chemotherapy2003

In vitro-in vivo model for evaluating the antiviral activity of amprenavir in combination with ritonavir administered at 600 and 100 milligrams, respectively, every 12 hours.

Sandra L Preston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.